Publication Date:
2012-10-12
Description:
MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition Oncogene 31, 4434 (11 October 2012). doi:10.1038/onc.2011.617 Authors: A Astanehe, M R Finkbeiner, M Krzywinski, A Fotovati, J Dhillon, I M Berquin, G B Mills, M A Marra & S E Dunn
Keywords:
trastuzumab resistancebreast cancerMNKRSKYB-1
Print ISSN:
0950-9232
Topics:
Medicine
Permalink